Apoptotic pathways triggered by HIV and consequences on T cell homeostasis and HIV-specific immunity.
Gougeon
M L
ML
Antiviral Immunity, Biotherapy and Vaccine Unit, Molecular Medicine Department, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris cedex 15, France. mlgougeo@pasteur.fr
D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D017209:Apoptosis / Q000502:physiology*; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology*; D016207:Cytokines / Q000276:immunology; D018450:Disease Progression; D006678:HIV / Q000378:metabolism*; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation
D019380:Anti-HIV Agents; D016207:Cytokines